Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Oct 22;13(10):e0206115.
doi: 10.1371/journal.pone.0206115. eCollection 2018.

Perceived barriers to the implementation of clinical pharmacy services in a metropolis in Northeast Brazil

Affiliations

Perceived barriers to the implementation of clinical pharmacy services in a metropolis in Northeast Brazil

Genival Araujo Dos Santos Júnior et al. PLoS One. .

Abstract

Background: CLinical pharmacy services (CPS) are professional services provided by pharmacists, who use their skills and knowledge to take an active role in patient health. These services have expanded in health systems around the world. However, it is important to have a comprehensive understanding of factors that may hinder the implementation of CPS in health systems.

Objective: To identify pharmacists' and managers' perceptions of barriers regarding the implementation of CPS in some public health units in a metropolis in Northeast Brazil.

Methods: This is a qualitative study based on focus groups and semi-structured, face-to-face, in-depth interviews. Participants were health-system pharmacists and managers, selected based on their direct participation in the implementation process. Focus groups were carried out with the pharmacists, and interviews were carried out with managers. The audio and videos were transcribed verbatim in full, and were independently analyzed using content analysis. This study was approved by the Brazilian Committee of Ethics in Research and all participants signed informed consent forms.

Findings: There were two focus groups and five interviews. The discussions generated 240 minutes of recordings. The health-system pharmacists and managers expressed barriers were allocated into five categories to facilitate a comprehensive understanding of the implementation of CPS; these barriers were related to: the local healthcare networks, the healthcare team, the pharmacists, the implementation process, and the patients.

Conclusions: This study revealed the perceptions of barriers associated with the participants involved in the implementation of CPS in some public health units in a metropolis in Northeast Brazil. The barriers reflect the challenges to be overcome in the CPS implementation process in the health systems.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Similar articles

Cited by

References

    1. Roberts AS, Benrimoj SIC, Chen TF, Williams KA. Implementing cognitive services in community pharmacy: a review of facilitators used in practice change. IJPP. 2006;14: 163–170. 10.1211/ijpp.14.3.0002 - DOI
    1. Buckley MS, Harinstein LM, Clark KB, Smithburger PL, Eckhardt DJ, Alexander E, et al. Impact of a clinical pharmacy admission medication reconciliation program on medication errors in “high-risk” patients. Ann Pharmacother. United States; 2013;47: 1599–1610. 10.1177/1060028013507428 - DOI - PubMed
    1. Preslaski CR, Lat I, MacLaren R, Poston J. Pharmacist Contributions as Members of the Multidisciplinary ICU Team. Chest. 2013;144: 1687–1695. 10.1378/chest.12-1615 - DOI - PubMed
    1. Gallagher J, McCarthy S, Byrne S. Economic evaluations of clinical pharmacist interventions on hospital inpatients: a systematic review of recent literature. Int J Clin Pharm. 2014;36: 1101–1114. 10.1007/s11096-014-0008-9 - DOI - PubMed
    1. Cheng Y, Raisch DW, Borrego ME, Gupchup G V. Economic, clinical, and humanistic outcomes (ECHOs) of pharmaceutical care services for minority patients: A literature review. Res Soc Adm Pharm. 2013;9: 311–329. 10.1016/j.sapharm.2012.05.004 - DOI - PubMed